Arthur G. Lipman, Pharm.D. - International Association for Hospice ...

Arthur G. Lipman
Page 33
CONTRIBUTED PAPERS (Continued)
24. Education and Service Directed Toward Meeting the Needs of the Elderly, American Association of Colleges of
Pharmacy 82nd Annual Meeting, Scottsdale, AZ, July 1981 (with M.D. Higbee and J.K. Devenport).
25. Patient Controlled Analgesia, Fourth World Conference on Pain, International Association for the Study of Pain, Seattle,
WA, August 1984 (with R. Kleiman and B. Hare).
26. Identification of Criteria Which May Promote Consistent Documentation of Clinical Pharmacy Activities, American
Society of Hospital Pharmacists 20th Annual Midyear Clinical Meeting, New Orleans, LA, December 1985 (with T.P.
Lennon, G.E. Dukes and L.M. Strand).
27. Pharmacological and psychological considerations in the management of pain due to metastatic prostatic cancer. Ninth
Annual Meeting of the Western U.S.A. Pain Society, Santa Fe, NM, May 1988 (with L.A. Czajkowski).
28. Development and implementation of standards of practice for a multiple institution system of hospitals and ambulatory
care centers. American Society of Hospital Pharmacists 24th Annual Midyear Clinical Meeting, Atlanta GA, December,
1989 (with RM Church, RN Herrier, EB Smith, RW Boyce, and V Dwight).
29. A system for concurrent data collection and retrospective analysis of advanced cancer pain and its management. VIth
World Congress on Pain, Adelaide, Australia, April, 1990 (with RG Twycross, S Johns and CD Cleeland).
30. Complications and Failed Pain Control with Chronic Epidural Pain Management: Mechanisms and Alternatives.
American Pain Society 15 th Annual Scientific meeting, Washington DC, November 1996 (with S DuPen, M Mauthier and
D Coombs).
31. Evidence-Based Drug Therapy Symptom Control Guidelines for Palliative Care. First International Conference on
Research in Palliative Care. National Institutes of Health and U.S. Cancer Pain Relief Committee, May 1998 ( with L.S.
Tyler)
32. Development and Implementation of Evidence-Based Medicine in Palliative Care. American Academy of Hospice and
Palliative Medicine 11th Annual Assembly, Snowbird UT, June 1999 ( with K Jackson).
33. A Successful Statewide Collaboration to Improve Care at the End of Life. American Academy of Hospice and Palliative
Medicine 11th Annual Assembly, Snowbird UT, June 1999 (with J Jacobson and S Beck).
34. Clinical Practice Guidelines: Making Recommendations Using Imperfect Science and Multiple Experts, American Pain
Society 18 th Annual Scientific Meeting, Fort Lauderdale FL, October 1999. (with C Miaskowski and A Jacox).
35. Opioid Analgesic Use in Chronic Nonmalignant Pain.. American Society of Health-System Pharmacists 34 th Annual
Midyear Clinical Meeting, Orlando FL, December, 1999 (with K Jackson and C Rubingh).
36. Iniital Efficacy Trial of topical Lidocaine Patches in the Management of Chronic Myofascial Pain. American Pain Society
Annual Meeting, Atlanta GA, November 2000. (with A Dalpiaz and S Lorden)
37. The Role of the Treatment Outcomes of Pain Survey Monitoring Health-Related Quality of Life. American Pain Society
Annual Meeting, Atlanta GA, November 2000. (with D Carr, W Roger, M Ashburn, G Oderda and J Schein)
38. Clinical Beliefs about Opioid Indications and Barriers in Chronic Nonmalignant Pain Management, American Pain
Society Annual Meeting, Atlanta GA, November 2000. (with P Grahmann and K Jackson)
39. Cost of Opioid Related Adverse Drug Events in Surgical Patients. American Society of Anesthesiologists 2001
Annual Meeting, October 2001, New Orleans LA. (with GM Oderda, M Samore, R Evans, C Chen, MA Ashburn, J
Burke)
40. Opioid-Related Adverse Drug Events and Costs in Surgical Patients. American College of Clinical Pharmacy
Annual Meeting. Tampa, Florida, October 2001. (with GM Oderda, RS Evans, J Lloyd, C Chen C., MA Ashburn, J
Burke and M Samore)
41. Cost of Opioid-Related Adverse Drug Events in Surgical Patients. American Society of Health Systems
Pharmacists, New Orleans LA, December 2001. (Encore Presentation). (with GM Oderda, RS Evans, J Lloyd, C
Chen, MA Ashburn, J Burke and M Samore)
42. Topical Lidocaine Patch Therapy for Myofascial Pain. American Pain Society Annual Scientific Meeting, Baltimore
MD, March 2002 (with A Dalpiaz and S Lorden)
43. Use of the TOPS as A Pain-Specific HRQOL Instrument. International Society for Pharmacoeconomics and
Outcomes Research Fifth European Congress, Rotterdam, The Netherlands, November 2002. (with GM Oderda, MA
Ashburn and W Stockdale)
44. Systematic Review of the Effects of Opioids and Pain on Human Immune Function. American Pain Society Annual
Scientific Meeting, Chicago IL March 2003 (with K Fakata and S Mullen)
-Continued-